Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems
- 5 May 2009
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 34 (3), 319-327
- https://doi.org/10.1111/j.1365-2710.2008.01017.x
Abstract
Background and objective: Due to drug-related problems (DRPs) that cause both unnecessary suffering and huge costs to society, many patients do not receive the intended beneficial effects of their treatment. Pharmacy practitioners have a key responsibility to respond to these problems, but more knowledge about the expected outcomes of their interventions is needed. The objective of the study was to assess the clinical and economic outcomes of community pharmacy interventions in patient DRPs. Methods: Drug-related problems in 13 different patient groups were identified and classified, according to the Westerlund System, by pharmacy practitioners from 89 Swedish pharmacies in 2006. The cases were documented in the pharmacy software and transferred to the national DRP database. An assessment model was developed and applied by the researchers (a pharmacist and a physician). This assessment was used to conduct a retrospective review by analysing the DRP and intervention documentation, in particular case descriptions from free text fields. Expected clinical patient outcomes of pharmacy interventions were judged in terms of improved therapeutic effects and prevented or relieved adverse drug reactions (ADRs). The review also assessed the expected patient outcomes with regard to initiated or avoided primary care contacts or avoided hospitalisations. The resulting hypothetically avoided direct societal costs and the estimated pharmacy personnel costs were calculated for the study and extrapolated to the Swedish nationwide level on an annual basis, to demonstrate the potential of national cost savings by pharmacy DRP-interventions. Results and discussion: In 358 cases (68%), the pharmacy interventions were judged to have produced an improved therapeutic effect in the patient, and in 172 cases (32%) to have prevented or relieved ADRs. Primary care contacts were initiated for 151 patients (29%), and pharmacy interventions were assessed to have saved 68 (13%) primary care contacts and 16 (3%) future hospitalisations. The potential societal cost savings extrapolated to Sweden at the national level were estimated at € 358 million. This is 37 times the expected pharmacy personnel costs for identifying and responding to the DRPs. Conclusion: Our study demonstrates that community pharmacy interventions in patient DRPs are most likely to lead to favourable clinical and economic outcomes. The convincing cost-benefit ratio should be presented to health care politicians and decision makers to encourage appropriate remuneration for these services.Keywords
This publication has 24 references indexed in Scilit:
- Pharmacist Care of Patients With Heart FailureA Systematic Review of Randomized TrialsArchives of Internal Medicine, 2008
- The Impact of Clinical Pharmacists on Drug‐Related Problems and Clinical OutcomesBasic & Clinical Pharmacology & Toxicology, 2008
- An innovative approach to integrated medicines managementJournal of Evaluation in Clinical Practice, 2007
- Which drugs cause preventable admissions to hospital? A systematic reviewBritish Journal of Clinical Pharmacology, 2006
- Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilizationPharmacoepidemiology and Drug Safety, 2005
- Evaluation of the clinical value of pharmacists’ modifications of prescription errorsBritish Journal of Clinical Pharmacology, 2004
- Adverse Drug Events in Ambulatory CareThe New England Journal of Medicine, 2003
- Adverse drug reactions as a cause for admissions to a department of internal medicinePharmacoepidemiology and Drug Safety, 2002
- Economic Impact of Increased Clinical Intervention Rates in Community PharmacyPharmacoEconomics, 2000
- Drug-related problems and pharmacy interventions in community practiceInternational Journal of Pharmacy Practice, 1999